XTANDI is a prescription medicine used to treat men with prostate cancer that:
OR
It is not known if XTANDI is safe and effective in females or children.
Non-metastatic castration-resistant prostate cancer (nmCRPC):
If you have this form, it means that your prostate cancer has not spread to other parts of the body and no longer responds to a hormone therapy or surgical treatment to lower testosterone.
Metastatic castration-sensitive prostate cancer (mCSPC):
If you have this form, it means that your prostate cancer has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone.
Metastatic castration-resistant prostate cancer (mCRPC):
If you have this form, it means that your prostate cancer has spread to other parts of the body and no longer responds to a hormone therapy or surgical treatment to lower testosterone.
The website you are about to visit is not owned or controlled by Astellas or Pfizer. Astellas and Pfizer are not responsible for the information or services on this site.
Please verify that you are a U.S. Healthcare Professional.
This information is intended for U.S. Healthcare Professionals only.